Pay in 4 interest-free payments of $6.60 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
In a study of experimental autoimmune myocarditis induced by cardiac troponin-I immunization (CTPN: SMD: 37.93, 95% CI 4.28, 71.58, p = 0.03), both the biomolecules, HMGB1 and RAGE (not computed) were considered as potential therapeutic targets in heart failure treatment, given the ability of HMGB1 to stimulate immunity and their ability to interact with each other, RAGE being its principal binding partner in both preclinical and clinical studies
PMID: 37946445
From our groundbreaking response to COVID-19 to our broad and deep menu of 3,500 routine, esoteric and genetic tests, we connect the most advanced solutions with healthcare providers and patientsregardless of where they are or what their health status is
[8] Son P, Lewis L
)
